Literature DB >> 22751537

Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy.

Giovanni Gherardi1, Fabio D'Ambrosio, Daniela Visaggio, Giordano Dicuonzo, Maria Del Grosso, Annalisa Pantosti.   

Abstract

The percentage of invasive penicillin-nonsusceptible pneumococci (PNSSP) isolated in Italy in the seven-valent pneumococcal conjugate vaccine (PCV7) era moderately increased in comparison to the pre-PCV7 era. Increase of nonvaccine serotypes was observed among PNSSP. The most frequent PNSSP clones were the same as those identified in the pre-PCV7 era, although they were present in different proportions. Clonal expansion, emergence of new clones, and acquisition of penicillin resistance by established clones contributed to the maintenance of penicillin resistance.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22751537      PMCID： PMC3421861          DOI： 10.1128/AAC.00830-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy.

Authors:  Annalisa Pantosti; Giovanni Gherardi; Marco Conte; Francesco Faella; Giordano Dicuonzo; Bernard Beall
Journal:  Clin Infect Dis       Date:  2002-06-19       Impact factor: 9.079

2.  Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era.

Authors:  William P Hanage; Susan S Huang; Marc Lipsitch; Cynthia J Bishop; Daniel Godoy; Stephen I Pelton; Richard Goldstein; Heather Huot; Jonathan A Finkelstein
Journal:  J Infect Dis       Date:  2006-12-27       Impact factor: 5.226

3.  Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine.

Authors:  Marc Lipsitch; Keith O'Neill; Derrick Cordy; Boris Bugalter; Krzysztof Trzcinski; Claudette M Thompson; Richard Goldstein; Stephen Pelton; Heather Huot; Valerie Bouchet; Raymond Reid; Mathuram Santosham; Katherine L O'Brien
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

4.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  Antibiotic-resistant invasive pneumococcal clones in Italy.

Authors:  Giovanni Gherardi; Loredana Fallico; Maria Del Grosso; Federica Bonanni; Fabio D'Ambrosio; Riccardo Manganelli; Giorgio Palù; Giordano Dicuonzo; Annalisa Pantosti
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

6.  Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.

Authors:  Heather E Hsu; Kathleen A Shutt; Matthew R Moore; Bernard W Beall; Nancy M Bennett; Allen S Craig; Monica M Farley; James H Jorgensen; Catherine A Lexau; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Cynthia G Whitney; Lee H Harrison
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

7.  Population structure of invasive Streptococcus pneumoniae isolates in Italy prior to the implementation of the 7-valent conjugate vaccine (1999-2003).

Authors:  G Gherardi; F D'Ambrosio; M Monaco; R Camilli; L De Florio; F D'Ancona; G Dicuonzo; A Pantosti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

8.  Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Authors:  Matthew R Moore; Robert E Gertz; Robyn L Woodbury; Genevieve A Barkocy-Gallagher; William Schaffner; Catherine Lexau; Kenneth Gershman; Arthur Reingold; Monica Farley; Lee H Harrison; James L Hadler; Nancy M Bennett; Ann R Thomas; Lesley McGee; Tamara Pilishvili; Angela B Brueggemann; Cynthia G Whitney; James H Jorgensen; Bernard Beall
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

9.  Streptococcus pneumoniae serotype 19A in children, South Korea.

Authors:  Eun Hwa Choi; So Hee Kim; Byung Wook Eun; Sun Jung Kim; Nam Hee Kim; Jina Lee; Hoan Jong Lee
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Authors:  Angela B Brueggemann; Rekha Pai; Derrick W Crook; Bernard Beall
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823
View more
  13 in total

1.  Noninvasive pneumococcal clones associated with antimicrobial nonsusceptibility isolated from children in the era of conjugate vaccines.

Authors:  Martha McElligott; Imelda Vickers; Mary Meehan; Mary Cafferkey; Robert Cunney; Hilary Humphreys
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

2.  Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.

Authors:  Uri Obolski; José Lourenço; Craig Thompson; Robin Thompson; Andrea Gori; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-06       Impact factor: 11.205

Review 3.  Mechanisms of genome evolution of Streptococcus.

Authors:  Cheryl P Andam; William P Hanage
Journal:  Infect Genet Evol       Date:  2014-11-13       Impact factor: 3.342

4.  Vaccination Drives Changes in Metabolic and Virulence Profiles of Streptococcus pneumoniae.

Authors:  Eleanor R Watkins; Bridget S Penman; José Lourenço; Caroline O Buckee; Martin C J Maiden; Sunetra Gupta
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

5.  Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy.

Authors:  Romina Camilli; Laura Daprai; Francesca Cavrini; Donatella Lombardo; Fabio D'Ambrosio; Maria Del Grosso; Maria Fenicia Vescio; Maria Paola Landini; Maria Grazia Pascucci; Erminio Torresani; Maria Laura Garlaschi; Vittorio Sambri; Annalisa Pantosti
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

6.  Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005-2010.

Authors:  Eliana L Parra; Viviana Ramos; Olga Sanabria; Jaime Moreno
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

7.  In-hospital management of children with bacterial meningitis in Italy.

Authors:  Marta Ciofi degli Atti; Susanna Esposito; Luciana Parola; Lucilla Ravà; Gianluigi Gargantini; Riccardo Longhi
Journal:  Ital J Pediatr       Date:  2014-11-14       Impact factor: 2.638

8.  Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.

Authors:  Jordi Càmara; José María Marimón; Emilia Cercenado; Nieves Larrosa; María Dolores Quesada; Dionísia Fontanals; Meritxell Cubero; Emilio Pérez-Trallero; Asunción Fenoll; Josefina Liñares; Carmen Ardanuy
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

9.  Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana.

Authors:  Deborah K Narwortey; Alex Owusu-Ofori; Hans-Christian Slotved; Eric S Donkor; Patrick O Ansah; Paul Welaga; Godfred Agongo; Abraham R Oduro
Journal:  BMC Infect Dis       Date:  2021-07-08       Impact factor: 3.090

10.  The post-vaccine microevolution of invasive Streptococcus pneumoniae.

Authors:  Amelieke J H Cremers; Fredrick M Mobegi; Marien I de Jonge; Sacha A F T van Hijum; Jacques F Meis; Peter W M Hermans; Gerben Ferwerda; Stephen D Bentley; Aldert L Zomer
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.